請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99848完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林先和 | zh_TW |
| dc.contributor.advisor | Hsien-Ho Lin | en |
| dc.contributor.author | 江翊潔 | zh_TW |
| dc.contributor.author | Yi-Chieh Chiang | en |
| dc.date.accessioned | 2025-09-18T16:11:26Z | - |
| dc.date.available | 2025-09-19 | - |
| dc.date.copyright | 2025-09-18 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-07-29 | - |
| dc.identifier.citation | 1. Gregg EW, Buckley J, Ali MK, Davies J, Flood D, Mehta R, Griffiths B, Lim LL, Manne-Goehler J, Pearson-Stuttard J, Tandon N, Roglic G, Slama S, Shaw JE; Global Health and Population Project on Access to Care for Cardiometabolic Diseases. Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet. 2023 Apr 15;401(10384):1302-1312. doi: 10.1016/S0140-6736(23)00001-6. Epub 2023 Mar 14. PMID: 36931289; PMCID: PMC10420388.
2. Yu NC, Chen IC. A decade of diabetes care in Taiwan. Diabetes Res Clin Pract. 2014 Dec;106 Suppl 2:S305-8. doi: 10.1016/S0168-8227(14)70734-X. PMID: 25550058. 3. Li CH, Li CC, Lu CL, Wu JS, Ku LE, Li CY. Urban-rural disparity in lower extremities amputation in patients with diabetes after nearly two decades of universal health Insurance in Taiwan. BMC Public Health. 2020 Feb 11;20(1):212. doi: 10.1186/s12889-020-8335-3. PMID: 32046698; PMCID: PMC7014711. 4. Wang YY, et al. Urban–rural disparities in the incidence of diabetes‐related complications: evidence from a nationwide cohort. J Clin Med. 2024. 5. Li HY, Wu YL, Tu ST, Hwu CM, Liu JS, Chuang LM. Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005-2014. J Formos Med Assoc. 2019 Nov;118 Suppl 2:S83-S89. doi: 10.1016/j.jfma.2019.07.008. Epub 2019 Jul 24. PMID: 31351690. 6. Tai SY, He JS, Kuo CT, Kawachi I. Urban-Rural Disparities in the Incidence of Diabetes-Related Complications in Taiwan: A Propensity Score Matching Analysis. J Clin Med. 2020 Sep 18;9(9):3012. doi: 10.3390/jcm9093012. PMID: 32962006; PMCID: PMC7565280. 7. Li CY, Chuang YC, Chen PC, Chen MS, Lee MC, Ku LE, Lee CB. Social Determinants of Diabetes-Related Preventable Hospitalization in Taiwan: A Spatial Analysis. Int J Environ Res Public Health. 2021 Feb 22;18(4):2146. doi: 10.3390/ijerph18042146. PMID: 33671762; PMCID: PMC7926970. 8. Sheen YJ, Hsu CC, Jiang YD, Huang CN, Liu JS, Sheu WH. Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019 Nov;118 Suppl 2:S66-S73. doi: 10.1016/j.jfma.2019.06.016. Epub 2019 Jul 9. PMID: 31300322. 9. Wang JS, Wu YL, Ou HY, Yang YS, Hsu CC, Hwu CM. Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan. Front Endocrinol (Lausanne). 2022 Aug 9;13:984137. doi: 10.3389/fendo.2022.984137. PMID: 36017319; PMCID: PMC9396277. 10. Wang JS, Yen FS, Lin KD, Shin SJ, Hsu YH, Hsu CC; Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan). Epidemiological characteristics of diabetic kidney disease in Taiwan. J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3. PMID: 34529360; PMCID: PMC8668071. 11. Hsu CC, Lee CH, Wahlqvist ML, Huang HL, Chang HY, Chen L, Shih SF, Shin SJ, Tsai WC, Chen T, Huang CT, Cheng JS. Poverty increases type 2 diabetes incidence and inequality of care despite universal health coverage. Diabetes Care. 2012 Nov;35(11):2286-92. doi: 10.2337/dc11-2052. Epub 2012 Aug 21. PMID: 22912425; PMCID: PMC3476930. 12. Tsuei SH. Reflection on 30 years of Taiwanese national health insurance: Analysis of Taiwanese health system progress, challenges, and opportunities. J Formos Med Assoc. 2024 Nov;123 Suppl 3:S180-S187. doi: 10.1016/j.jfma.2024.07.030. Epub 2024 Aug 1. PMID: 39089963. 13. Institute of Medicine (US) Committee on Guidance for Designing a National Healthcare Disparities Report; Swift EK, editor. Guidance for the National Healthcare Disparities Report. Washington (DC): National Academies Press (US); 2002. 5, GEOGRAPHY AND DISPARITIES IN HEALTH CARE. 14. Chen PC, Tsai CY, Woung LC, Lee YC. Socioeconomic disparities in preventable hospitalization among adults with diabetes in Taiwan: a multilevel modelling approach. Int J Equity Health. 2015 Mar 21;14:31. doi: 10.1186/s12939-015-0160-4. PMID: 25889800; PMCID: PMC4377057. 15. Hsieh, CL., Chung, CY., Chen, HY. et al. Bridging geographical disparities across 368 townships with healthcare system and socioeconomic factors in Taiwan. Sci Rep 13, 15007 (2023). 16. Khoury MJ, Iademarco MF, Riley WT. Precision Public Health for the Era of Precision Medicine. Am J Prev Med. 2016 Mar;50(3):398-401. doi: 10.1016/j.amepre.2015.08.031. Epub 2015 Nov 4. PMID: 26547538; PMCID: PMC4915347. 17. Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012 Spring;9(1):6-22. doi: 10.1900/RDS.2012.9.6. Epub 2012 May 10. PMID: 22972441; PMCID: PMC3448170. 18. Franks PW. The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overview. Scientifica (Cairo). 2012;2012:482186. doi: 10.6064/2012/482186. Epub 2012 Oct 8. PMID: 24278702; PMCID: PMC3820646. 19. Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013 Aug 15;4(4):114-23. doi: 10.4239/wjd.v4.i4.114. PMID: 23961321; PMCID: PMC3746083. 20. Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013 Dec;13(6):814-23. doi: 10.1007/s11892-013-0421-9. PMID: 24037313; PMCID: PMC3830901. 21. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22. Erratum in: Lancet. 2023 Sep 30;402(10408):1132. doi: 10.1016/S0140-6736(23)02044-5. Erratum in: Lancet. 2025 Jan 18;405(10474):202. doi: 10.1016/S0140-6736(25)00053-4. PMID: 37356446; PMCID: PMC10364581. 22. Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. J Diabetes Res. 2021 Oct 7;2021:7796727. doi: 10.1155/2021/7796727. PMID: 34660812; PMCID: PMC8516544. 23. D Haire-Joshu, R E Glasgow, T L Tibbs; Smoking and diabetes.. Diabetes Care 1 November 1999; 22 (11): 1887–1898. 24. Qin L, Knol MJ, Corpeleijn E, Stolk RP. Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol. 2010;25(1):5-12. doi: 10.1007/s10654-009-9395-y. Epub 2009 Oct 22. PMID: 19847656; PMCID: PMC2807936. 25. Chaput, Jean-Philippe, Klingenberg, Lars, Rosenkilde, Mads, Gilbert, Jo-Anne, Tremblay, Angelo, Sjödin, Anders, Physical Activity Plays an Important Role in Body Weight Regulation, Journal of Obesity, 2011, 360257, 11 pages, 2011. 26. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007 Dec 12;298(22):2654-64. doi: 10.1001/jama.298.22.2654. PMID: 18073361. 27. Bajaj M. Nicotine and insulin resistance: when the smoke clears. Diabetes. 2012 Dec;61(12):3078-80. doi: 10.2337/db12-1100. PMID: 23172960; PMCID: PMC3501863. 28. Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016. JAMA Intern Med. 2019 Oct 1;179(10):1376-1385. doi: 10.1001/jamainternmed.2019.2396. PMID: 31403657; PMCID: PMC6692836. 29. Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, Thornton PL, Haire-Joshu D. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020 Nov 2;44(1):258–79. doi: 10.2337/dci20-0053. Epub ahead of print. PMID: 33139407; PMCID: PMC7783927. 30. Mahasin S. Mujahid, Sai Ramya Maddali, Xing Gao, Khin H. Oo, Larissa A. Benjamin, Tené T. Lewis; The Impact of Neighborhoods on Diabetes Risk and Outcomes: Centering Health Equity. Diabetes Care 1 September 2023; 46 (9): 1609–1618. 31. Wong TJ, Yu T (2022) Trends in the distribution of body mass index, waist circumference and prevalence of obesity among Taiwanese adults, 1993–2016. PLOS ONE 17(9): e0274134. https://doi.org/10.1371/journal.pone.0274134 32. Chen C, Tsai L-T, Lin C-F, Huang C-C, Chang Y-T, Chen R-Y, et al. (2017) Factors influencing interest in recreational sports participation and its rural-urban disparity. PLoS ONE 12(5): e0178052. 33. Cheng TY, Wen CP, Tsai SP, Chung WS, Hsu CC. Reducing health disparity in Taiwan: quantifying the role of smoking. Tob Control. 2005 Jun;14 Suppl 1(Suppl 1):i23-7. doi: 10.1136/tc.2003.005546. PMID: 15923443; PMCID: PMC1766179. 34. Li S, Wang J, Zhang B, Li X, Liu Y. Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study. Diabetes Metab J. 2019 Jun;43(3):319-341. doi: 10.4093/dmj.2018.0060. PMID: 31210036; PMCID: PMC6581547. 35. Yang JJ, Yu D, Wen W, et al. Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA Netw Open. 2019;2(4):e192696. doi:10.1001/jamanetworkopen.2019.2696 36. Jacqueline A. Seiglie, Edson Serván-Mori, Tahmina Begum, James B. Meigs, Deborah J. Wexler, Veronika J. Wirtz, Predictors of health facility readiness for diabetes service delivery in low- and middle-income countries: The case of Bangladesh, Diabetes Research and Clinical Practice, Volume 169, 2020, 108417, ISSN 0168-8227. 37. Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, et al. (2019) Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLOS Medicine 16(3): e1002751. 38. Barnes AS. The epidemic of obesity and diabetes: trends and treatments. Tex Heart Inst J. 2011;38(2):142-4. PMID: 21494521; PMCID: PMC3066828. 39. Muh-Shy Chen, Chie-Shung Kao, Chih-Jen Chang, Ta-Jen Wu, Chen-Chung Fu, Chien-Jen Chen, Tong-Yuan Tai, Prevalence and Risk Factors of Diabetic Retinopathy Among Noninsulin-dependent Diabetic Subjects, American Journal of Ophthalmology, Volume 114, Issue 6, 1992, Pages 723-730, ISSN 0002-9394. 40. Hsu CC, Tu ST, Sheu WH. 2019 Diabetes Atlas: Achievements and challenges in diabetes care in Taiwan. J Formos Med Assoc. 2019 Nov;118 Suppl 2:S130-S134. doi: 10.1016/j.jfma.2019.06.018. Epub 2019 Aug 3. PMID: 31387840. 41. Leila Ismail, Huned Materwala, Juma Al Kaabi, Association of risk factors with type 2 diabetes: A systematic review, Computational and Structural Biotechnology Journal, Volume 19, 2021, Pages 1759-1785, ISSN 2001-0370, 42. Simon, G.J., Peterson, K.A., Castro, M.R. et al. Predicting diabetes clinical outcomes using longitudinal risk factor trajectories. BMC Med Inform Decis Mak 20, 6 (2020). 43. Wu YC, Lo WC, Lu TH, Chang SS, Lin HH, Chan CC. Mortality, morbidity, and risk factors in Taiwan, 1990-2017: findings from the Global Burden of Disease Study 2017. J Formos Med Assoc. 2021 Jun;120(6):1340-1349. doi: 10.1016/j.jfma.2020.11.014. Epub 2020 Dec 10. PMID: 33309080. 44. Nanditha, Ni Gusti Ayu, et al. "The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada." BMC Medical Research Methodology 22.1 (2022): 1. 45. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2. PMID: 33069327; PMCID: PMC7566194. 46. Charles, V., Gherman, T., Paliza, J.C. (2022). The Gini Index: A Modern Measure of Inequality. In: Charles, V., Emrouznejad, A. (eds) Modern Indices for International Economic Diplomacy. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-84535-3_3 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99848 | - |
| dc.description.abstract | 背景:糖尿病(Diabetes Mellitus, DM)是一種全球盛行的代謝性疾病,對公共衛生構成長期且日益嚴峻的挑戰。糖尿病經常伴隨多種潛在併發症,並對個人與整體社會造成顯著的醫療與經濟負擔。在臺灣,雖然近年(2017–2021年)糖尿病的發生率與盛行率趨於穩定,且死亡率並未顯著上升,但相關危險因子與糖尿病健康結果(如發生率與死因別死亡率)在各縣市間仍呈現顯著的地理差異,反映出明確的區域性健康不平等現象。
目的:本研究旨在建構完整的疾病歷程架構,包含「危險因子暴露」→「疾病發生」→「醫療照護(診斷與治療)」→「死亡」的進程,並探討其中健康不平等最為顯著、可被解釋與最具介入潛力的環節。本研究更進一步解析臺灣各縣市間糖尿病健康結果及其相關危險因子分布的地理差異,並量化三項主要可修正之危險因子──高身體質量指數(High BMI)、身體活動量不足(Physical Inactivity)與吸菸行為(Smoking)──對糖尿病發生率不平等的貢獻程度。 方法:本研究涵蓋2017至2021年,並整合臺灣健保資料庫(NHIRD)、國民健康訪問調查(NHIS)、營養健康狀況變遷調查(NAHSIT)與國人死因統計檔,分析糖尿病發生率、死因別死亡率、死亡對發病比(MI ratio)、治療覆蓋率及血糖控制率等指標,並針對三項主要危險因子估算其單獨與聯合之族群可歸因分率(Population Attributable Fraction, PAF)。本研究進一步運用變異係數(Coefficient of Variation, CV)作為地區不平等分析工具,比較縣市別糖尿病發生率的目前情境與使用PAF估計移除某危險因子後之縣市別糖尿病發生率反事實情境,兩情境下變異係數之改變,以量化各危險因子對地理空間差異的解釋力。 結果:研究顯示,臺灣各縣市間在糖尿病相關健康指標上存在明顯的區域性差異。東部地區(如花蓮縣、臺東縣)具有較高的糖尿病發生率;花蓮縣與屏東縣之糖尿病死亡率亦居各縣市前列;部分中南部縣市則是在治療覆蓋率及血糖控制成功率方面表現相對落後。在三項主要危險因子當中,高BMI之族群可歸因分率最高(男性介於33.24%至45.72%;女性介於17.55%至42.67%),對糖尿病發生率的整體貢獻最大;相較之下,身體活動量不足(男性介於14.90%至17.92%;女性介於13.80%至18.83%)與吸菸(男性介於12.75%至21.98%;女性介於0.23%至2.84%)之貢獻度明顯較低。進一步以目前與反事實情境下變異係數改變量之分析後發現,男性高BMI對縣市間糖尿病發生率差異之解釋力最高(3.45%);女性則以身體活動量不足為最(1.18%)。然而,這三項因子之解釋力皆不足以全面說明地理不平等,顯示尚有其他潛在因素驅動臺灣地區糖尿病發生的不平等分布。整體而言,研究結果突顯出目前既有策略在應對地區性健康不平等方面的侷限,亦顯示需針對具代表性的危險因子採取更差異化的政策。 結論:本研究強調糖尿病防治策略應具備地區化與性別導向特性,並呼籲將肥胖防治納入政策核心,作為減少糖尿病負擔與健康不平等的首要目標。研究亦透過CV方法量化並分解不平等來源,提供精準公共衛生於規劃中的資源配置與介入優先順序之實證依據。 | zh_TW |
| dc.description.abstract | Background: Diabetes Mellitus (DM) is a globally prevalent metabolic disorder, representing a persistent public health challenge. It is frequently accompanied by a wide range of complications and imposes a substantial medical and economic burden on individuals and society. In Taiwan, while the incidence and prevalence of diabetes remained relatively stable during the study period from 2017 to 2021, and the diabetes-specific mortality did not exhibit a significant upward trend, there are still notable geographical disparities persisting across counties in both diabetes-related outcomes as well as in the distribution of associated risk factors. These variations in both outcomes and risk factor distributions reflect pronounced regional health inequalities.
Objectives: This study aims to conceptualize the full disease pathway framework, including “risk exposure” → “disease onset” → “healthcare access (diagnosis and treatment)” → “diabetes-attributable mortality”, seeking to identify the stages where disparities are most pronounced, most attributable, and most amenable to intervention. This study also aims to analyze the geographical disparities in diabetes-related health outcomes and associated risk factor distributions across Taiwan’s counties, and to further quantify and decompose the contributions of three major modifiable risk factors—high body mass index (BMI), physical inactivity, and smoking—to the observed inequalities in diabetes incidence. Methodology: This study analyzes data from 2017 to 2021, using nationally representative sources: National Health Insurance Research Database (NHIRD), National Health Interview Survey (NHIS), Nutrition and Health Survey in Taiwan (NAHSIT), and Cause of Death Data. Key diabetes-related indicators, including incidence, diabetes-attributable mortality, mortality-to-incidence ratio (MI-Ratio), treatment coverage, and glycemic control, are assessed across regions. Population Attributable Fractions (PAFs) are estimated for high body mass index (BMI), physical inactivity, and smoking, being calculated both individually and jointly, which are also disaggregated by sex and geographic unit. This study further employed the Coefficient of Variation (CV) as a tool to analyze reginal inequality by comparing county-level diabetes incidence under the current scenario with a counterfactual scenario in which the population-attributable fraction (PAF) for each risk factor was removed. The change in CV between the two scenarios is used to qualify the explanatory power of individual risk factors on spatial disparities. Results: The findings reveal persistent geographical inequalities in diabetes-related health indicators across Taiwan. Eastern regions such as 花蓮縣and臺東縣 exhibit higher diabetes incidence; 花蓮縣 and 屏東縣exhibit elevated diabetes-specific mortality; several central and southern counties demonstrate relatively low treatment coverage and suboptimal glycemic control rates. Among the three risk factors, high BMI demonstrates the highest average population attributable fraction (PAF) across counties (males range from 33.24% to 45.72%; females range from 17.55% to 42.67%), indicating its dominant contribution to diabetes incidence. In comparison, the PAFs for physical inactivity (males range from 14.90% to17.92%; females range from 13.80%% to 18.83%) and for smoking (males range from12.75% to 21.98%; females range from 0.23% to 2.84%) have lower attribution. Further analysis of the difference in CV between the current and counterfactual scenarios indicates that, for males, high BMI have the strongest explanatory power for inter-county disparities in diabetes incidence (3.45%); among females, physical inactivity accounts for the greatest proportion (1.18%). However, the explanatory power of all the three risk factors remains limited, suggesting the presence of other unmeasured factors potentially driving the unequal geographic distribution of diabetes incidence in Taiwan. Conclusion: This study underscores the importance of implementing geographically and gender-sensitive diabetes prevention strategies in Taiwan, with an emphasis on obesity reduction as a core public health policy priority to reduce the burden of diabetes. By applying Coefficient of Variation (CV) as decomposition methods to quantify the sources of disparities, the study provides an empirical foundation for precision public health planning, including targeted resource allocation and prioritized interventions. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-18T16:11:26Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-09-18T16:11:26Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 摘要 1
Abstract 3 Chapter 1 Introduction 8 1.1 Background 8 1.2 Diabetes and Its Driving Risk Factors 9 1.3 Research Gaps 10 1.4 Study Aims 12 Chapter 2 Methodology 14 2.1 Data Sources 14 2.2 Study Population, Inclusion and Exclusion Criteria 15 2.3 Measurement of Diabetes Outcomes 17 2.3.1 Incidence Rate 17 2.3.2 Diabetes-Specific Mortality Rate 18 2.3.3 Mortality-To-Incidence Ratio (MI-Ratio) 18 2.4 Risk Factors 19 2.4.1 High Body Mass Index (BMI) 19 2.4.2 Physical Inactivity 20 2.4.3 Smoking 20 2.5 Population Attributable Fraction (PAF) 21 2.5.1 Continuous PAF 21 2.5.2 Categorical PAF 22 2.5.3 Overall PAF Estimation 23 2.5.4 Joint PAF (High BMI, Physical Inactivity, and Smoking) Estimation 23 2.6 Statistical Decomposition Analysis 24 2.6.1 Coefficient of Variation (CV) 24 2.7 Diabetes Care 27 2.7.1 Treatment Coverage 27 2.7.2 Treatment-Adjusted Incidence 29 2.7.3 Management (Well-Controlled) Rate 30 2.8 Visualization 31 Chapter 3 Results 32 3.1 Incidence Rate 32 3.2 Diabetes-Specific Mortality Rate 33 3.3 Mortality-To-Incidence Ratio (MI-Ratio) Based on Observed Incidence 35 3.4 PAF of High BMI 36 3.5 PAF of Physical Inactivity 37 3.6 PAF of Smoking 38 3.7 Joint PAF of High BMI, Physical Inactivity, and Smoking 38 3.8 Statistical Decomposition Analysis 39 3.9 Treatment Coverage 41 3.10 Treatment-Adjusted Incidence 43 3.11 MI-Ratio Based on Treatment-Adjusted Incidence 44 3.12 Management (Well-Controlled) Rate 45 Chapter 4 Discussion 47 4.1 Main Findings 47 4.2 Comparisons with Existing Literature 48 4.3 Strengths 49 4.4 Limitations and Further Work 50 4.5 Public Health Implications 52 4.6 Conclusion 53 Chapter 6 Tables 54 Chapter 7 Figures 56 Reference 74 Appendices 83 Appendix 1. Diabetes Inclusion: 83 Appendix 2. Diabetes Exclusion: 84 Appendix 3. Relative Risk (RR) Table by GBD (Provided by IHME): 84 Appendix 4. Incidence vs Mortality: 85 | - |
| dc.language.iso | en | - |
| dc.subject | 健康不平等 | zh_TW |
| dc.subject | 糖尿病 | zh_TW |
| dc.subject | 危險因子 | zh_TW |
| dc.subject | Risk Factor | en |
| dc.subject | Diabetes | en |
| dc.subject | Health Disparities | en |
| dc.title | 臺灣地區糖尿病健康結果與危險因子解構之地理差異:一項區域性健康不平等的全面研究 | zh_TW |
| dc.title | Geographical Disparities in Diabetes Outcomes and Risk Factors Decomposition in Taiwan: A Comprehensive Study of Regional Health Disparities | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 李文宗;羅偉成 | zh_TW |
| dc.contributor.oralexamcommittee | Wen-Chung Lee;Wei-Cheng Lo | en |
| dc.subject.keyword | 糖尿病,健康不平等,危險因子, | zh_TW |
| dc.subject.keyword | Diabetes,Health Disparities,Risk Factor, | en |
| dc.relation.page | 89 | - |
| dc.identifier.doi | 10.6342/NTU202502567 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2025-07-29 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | - |
| dc.date.embargo-lift | 2025-09-19 | - |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-2.pdf | 12.98 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
